BioCentury
ARTICLE | Company News

MannKind management update

January 26, 2015 8:00 AM UTC

MannKind Corp. (NASDAQ:MNKD), Valencia, Calif. Business: Endocrine/Metabolic, Cancer Resigned: Alfred Mann as CEO, while remaining chairman; he is succeeded by President Hakan Edstrom, who resigned as...